Continued evasion of neutralizing antibody response by Omicron XBB.1.16
Summary: The evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to challenge the efficacy of vaccination efforts against coronavirus disease 2019 (COVID-19). The Omicron XBB lineage of SARS-CoV-2 has presented dramatic evasion of neutralizing antibodies stimulated by...
Main Authors: | Julia N. Faraone, Panke Qu, Yi-Min Zheng, Claire Carlin, Daniel Jones, Ashish R. Panchal, Linda J. Saif, Eugene M. Oltz, Richard J. Gumina, Shan-Lu Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-10-01
|
Series: | Cell Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124723012056 |
Similar Items
-
Enhanced evasion of neutralizing antibody response by Omicron XBB.1.5, CH.1.1, and CA.3.1 variants
by: Panke Qu, et al.
Published: (2023-05-01) -
Omicron BQ.1.1 and XBB.1 unprecedentedly escape broadly neutralizing antibodies elicited by prototype vaccination
by: Bin Ju, et al.
Published: (2023-06-01) -
Structures of Omicron spike complexes and implications for neutralizing antibody development
by: Hangtian Guo, et al.
Published: (2022-05-01) -
Potent Omicron-neutralizing antibodies isolated from a patient vaccinated 6 months before Omicron emergence
by: Kathryn M. Hastie, et al.
Published: (2023-05-01) -
Durability of neutralization against Omicron subvariants after vaccination and breakthrough infection
by: Ka-Li Zhu, et al.
Published: (2023-02-01)